ES8700242A1 - Un procedimiento para preparar un derivado de dihidropirida-zinona - Google Patents

Un procedimiento para preparar un derivado de dihidropirida-zinona

Info

Publication number
ES8700242A1
ES8700242A1 ES543236A ES543236A ES8700242A1 ES 8700242 A1 ES8700242 A1 ES 8700242A1 ES 543236 A ES543236 A ES 543236A ES 543236 A ES543236 A ES 543236A ES 8700242 A1 ES8700242 A1 ES 8700242A1
Authority
ES
Spain
Prior art keywords
formula
pharmaceutically acceptable
chemical compounds
dihydropirizazinone
vasodilators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543236A
Other languages
English (en)
Spanish (es)
Other versions
ES543236A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES543236A0 publication Critical patent/ES543236A0/es
Publication of ES8700242A1 publication Critical patent/ES8700242A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES543236A 1984-05-19 1985-05-17 Un procedimiento para preparar un derivado de dihidropirida-zinona Expired ES8700242A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848412864A GB8412864D0 (en) 1984-05-19 1984-05-19 Chemical compounds

Publications (2)

Publication Number Publication Date
ES543236A0 ES543236A0 (es) 1986-09-16
ES8700242A1 true ES8700242A1 (es) 1986-09-16

Family

ID=10561228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543236A Expired ES8700242A1 (es) 1984-05-19 1985-05-17 Un procedimiento para preparar un derivado de dihidropirida-zinona

Country Status (11)

Country Link
US (1) US4652563A (2)
EP (1) EP0168921A3 (2)
JP (1) JPS60255776A (2)
AU (1) AU4260585A (2)
DK (1) DK216285A (2)
ES (1) ES8700242A1 (2)
FI (1) FI851979A0 (2)
GB (1) GB8412864D0 (2)
GR (1) GR851200B (2)
PT (1) PT80488B (2)
ZA (1) ZA853739B (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
US4931430A (en) * 1987-12-14 1990-06-05 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ACE inhibitor
US5096904A (en) * 1989-09-01 1992-03-17 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activities
US5495023A (en) * 1991-11-15 1996-02-27 Fujisawa Pharmaceutical Co., Ltd. Nitro compounds, process for preparation thereof and use thereof
US5969017A (en) * 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US20030069318A1 (en) * 2001-08-21 2003-04-10 Wenbin Dang Salts of analgesic substances in oil, and methods of making and using the same
CA2533013C (en) * 2003-07-17 2011-07-26 Banner Pharmacaps, Inc. Controlled release preparations
CN1300079C (zh) * 2004-12-03 2007-02-14 南京大学 合成4-[2-(环丙基甲氧基)乙基]苯酚的新工艺
FR3036396B1 (fr) * 2015-05-22 2020-02-28 Axon Cable Composition de verre pour le scellement de connecteur micro-d

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS58146570A (ja) * 1982-02-25 1983-09-01 Teikoku Hormone Mfg Co Ltd ピリダジノン誘導体

Also Published As

Publication number Publication date
GR851200B (2) 1985-11-25
DK216285A (da) 1985-11-20
AU4260585A (en) 1985-11-21
FI851979A0 (fi) 1985-05-17
ES543236A0 (es) 1986-09-16
GB8412864D0 (en) 1984-06-27
EP0168921A2 (en) 1986-01-22
US4652563A (en) 1987-03-24
PT80488B (en) 1987-04-21
JPS60255776A (ja) 1985-12-17
DK216285D0 (da) 1985-05-15
PT80488A (en) 1985-06-01
ZA853739B (en) 1986-12-30
EP0168921A3 (en) 1986-11-05

Similar Documents

Publication Publication Date Title
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
ES8604964A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
ES8103753A1 (es) Procedimiento para la preparacion de acidos 3-cefem-4-carbo-xilicos sustituidos en la posicion 7
DK504183A (da) Guaninderivater og fremgangsmaade til fremstilling deraf
PT88992A (pt) Processo para a preparacao de compostos contendo fosforo uteis como inibidores de colagenase
ES8707733A1 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES557664A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
ATE18218T1 (de) Antifungische triazolyl-propanol-derivate.
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
ES8604562A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina e isoquinolina
ES2054806T3 (es) Cicloalquilamidas de (8beta)-1-alquil-6-(sustituido)-ergolinas.
ES8306741A1 (es) "un procedimiento para la preparacion de 4-(4-imidazolil)-piridinas 2-sustituidas".
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
ES8707723A1 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina
ES2064361T3 (es) Nuevos compuestos.
ES2029836T3 (es) Procedimiento para preparar un derivado de pristinamicina.
ES8500953A1 (es) Procedimiento para preparar derivados de tieno-tiazol
AR240825A2 (es) Procedimiento para obtener compuestos de 7-(2-aminotiazol-4-il-acetamido-3(((1-(2-dimetil aminoetil)-1h-tetrazol-5-il)tio)metil)-cef-3-em-4-carboxilato y sus sales
ES554474A0 (es) Un procedimiento para la preparacion de derivados de carbapenem.
ES8504771A1 (es) Un procedimiento para preparar derivados de piridina
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ES8304920A1 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.